1
|
Pellecchia MT, Picillo M, Russillo MC, Andreozzi V, Oliveros C, Cattaneo C. The effects of safinamide according to gender in Chinese parkinsonian patients. Sci Rep 2023; 13:20632. [PMID: 37996493 PMCID: PMC10667246 DOI: 10.1038/s41598-023-48067-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Accepted: 11/22/2023] [Indexed: 11/25/2023] Open
Abstract
The incidence and prevalence of Parkinson's disease (PD) is expected to raise dramatically over the next decades. Gender-related differences are not yet widely recognized, particularly regarding the response to dopaminergic medications. To analyse gender differences in the clinical effects of safinamide, compared to placebo, in Chinese PD patients of the pivotal XINDI trial. The XINDI study was a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Patients were followed for 16 weeks receiving safinamide or placebo as add-on to levodopa. The primary efficacy endpoint was the change in the mean total daily OFF time. Secondary efficacy endpoints included total daily ON time, ON time with no/non-troublesome dyskinesia, Unified Parkinson's Disease Rating Scale and Parkinson's Disease Questionnaire-39 items. A post-hoc analysis was performed to describe the efficacy of safinamide in both genders on motor symptoms, motor fluctuations and quality of life. 128 (42%) out of 305 patients enrolled were women and 177 (58%) men. Our additional analyses of the XINDI study have shown that safinamide, compared to placebo, was associated with improvements in motor symptoms, motor fluctuations and quality of life in both genders, with some differences in the response that did not reach statistical significance, possibly due to sample size limitation and post-hoc design of the study. The changes from baseline at week 16 were > 50% higher in the females compared to males for the total daily OFF time (- 1.149 h vs - 0.764 h in males), the total daily ON time (1.283 h vs 0.441 h in males), the UPDRS total score (- 8.300 points vs - 5.253 points in males) and the UPDRS part II score (- 2.574 points vs - 1.016 points in males). The changes from baseline at week 16 were higher in the females compared to males in the "ADL" domain (- 6.965 points vs - 5.772 points in males), the "Emotional well-being" domain (- 6.243 points vs - 4.203 in males), the "Stigma" domain (- 6.185 points vs - 4.913 points in males) and the "Bodily discomfort" domain (- 5.196 points vs 1.099 points in males), while were higher in males in the "Mobility" score (- 6.523 points vs - 4.961 points in females) and the "Communication" score (- 3.863 points vs - 1.564 points in females). Safinamide was shown to improve PD symptoms and quality of life in both male and female Chinese patients. Possible differences in the response between genders need to be further studied in larger and different ethnic populations.
Collapse
Affiliation(s)
- M T Pellecchia
- Neuroscience Section, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy.
| | - M Picillo
- Neuroscience Section, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - M C Russillo
- Neuroscience Section, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - V Andreozzi
- Neuroscience Section, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84131, Salerno, Italy
| | - C Oliveros
- Medical Department, Zambon SpA, Bresso, Italy
| | - C Cattaneo
- Medical Department, Zambon SpA, Bresso, Italy
| |
Collapse
|
2
|
Vallelunga A, Iannitti T, Somma G, Russillo MC, Picillo M, De Micco R, Vacca L, Cilia R, Cicero CE, Zangaglia R, Lazzeri G, Galantucci S, Radicati FG, De Rosa A, Amboni M, Scaglione C, Tessitore A, Stocchi F, Eleopra R, Nicoletti A, Pacchetti C, Di Fonzo A, Volontè MA, Barone P, Pellecchia MT. Correction to: Gender differences in microRNA expression in levodopa‑naive PD patients. J Neurol 2023:10.1007/s00415-023-11750-x. [PMID: 37154896 DOI: 10.1007/s00415-023-11750-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Affiliation(s)
- A Vallelunga
- Department of Life Sciences and Biotechnologies, Section of Medicines and Health Products, University of Ferrara, Ferrara, Italy
| | - T Iannitti
- Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, Ferrara, Italy
| | - G Somma
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - M C Russillo
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - M Picillo
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - R De Micco
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - L Vacca
- IRCCS San Raffaele, Rome, Italy
| | - R Cilia
- Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - C E Cicero
- Neurologic Unit, AOU "Policlinico-San Marco", Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy
| | - R Zangaglia
- Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy
| | - G Lazzeri
- IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy
| | - S Galantucci
- IRCCS San Raffaele Scientific Institute, Neurology Unit, Milan, Italy
| | | | - A De Rosa
- IRCCS San Raffaele, Rome, Italy
- Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - M Amboni
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - C Scaglione
- IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - A Tessitore
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - F Stocchi
- IRCCS San Raffaele, Rome, Italy
- University San Raffaele, Roma, Italy
| | - R Eleopra
- Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - A Nicoletti
- Neurologic Unit, AOU "Policlinico-San Marco", Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy
| | - C Pacchetti
- Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy
| | - A Di Fonzo
- IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy
| | - M A Volontè
- IRCCS San Raffaele Scientific Institute, Neurology Unit, Milan, Italy
| | - P Barone
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - M T Pellecchia
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy.
| |
Collapse
|
3
|
Vallelunga A, Iannitti T, Somma G, Russillo MC, Picillo M, De Micco R, Vacca L, Cilia R, Cicero CE, Zangaglia R, Lazzeri G, Galantucci S, Radicati FG, De Rosa A, Amboni M, Scaglione C, Tessitore A, Stocchi F, Eleopra R, Nicoletti A, Pacchetti C, Di Fonzo A, Volontè MA, Barone P, Pellecchia MT. Gender differences in microRNA expression in levodopa-naive PD patients. J Neurol 2023:10.1007/s00415-023-11707-0. [PMID: 37052669 DOI: 10.1007/s00415-023-11707-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2023] [Revised: 04/01/2023] [Accepted: 04/03/2023] [Indexed: 04/14/2023]
Abstract
Gender is an important factor influencing epidemiological and clinical features of Parkinson's disease (PD). We aimed to evaluate gender differences in the expression of a panel of miRNAs (miR-34a-5p, miR-146a, miR-155, miR-29a, miR-106a) possibly involved in the pathophysiology or progression of disease. Serum samples were obtained from 104 PD patients (58 men and 46 women) never treated with levodopa. We measured levels of miRNAs using quantitative PCR. Correlations between miRNA expression and clinical data were assessed using the Spearman's correlation test. We used STRING to evaluate co-expression relationship among target genes. MiR-34a-5p was significantly upregulated in PD male patients compared to PD female patients (fc: 1.62; p < 0.0001). No correlation was found with age, BMI, and disease severity, assessed by UPDRS III scale, in male and female patients. MiR-146a-5p was significantly upregulated in female as compared to male patients (fc: 3.44; p < 0.0001) and a significant correlation was also observed between disease duration and mir-146a-5p. No differences were found in the expression of miR-29a, miR-106a-5p and miR-155 between genders. Predicted target genes for miR-34a-5p and miR-146-5p and protein interactions in biological processes were reported. Our study supports the hypothesis that there are gender-specific differences in serum miRNAs expression in PD patients. Follow-up of this cohort is needed to understand if these differences may affect disease progression and response to treatment.
Collapse
Affiliation(s)
- A Vallelunga
- Department of Life Sciences and Biotechnologies, Section of Medicines and Health Products, University of Ferrara, Ferrara, Italy
| | - T Iannitti
- Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, Ferrara, Italy
| | - G Somma
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - M C Russillo
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - M Picillo
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - R De Micco
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - L Vacca
- IRCCS San Raffaele, Rome, Italy
| | - R Cilia
- Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - C E Cicero
- Neurologic Unit, AOU "Policlinico-San Marco", Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy
| | - R Zangaglia
- Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy
| | - G Lazzeri
- IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy
| | - S Galantucci
- IRCCS San Raffaele Scientific Institute, Neurology Unit, Milan, Italy
| | | | - A De Rosa
- IRCCS San Raffaele, Rome, Italy
- Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - M Amboni
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - C Scaglione
- IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy
| | - A Tessitore
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - F Stocchi
- IRCCS San Raffaele, Rome, Italy
- University San Raffaele, Roma, Italy
| | - R Eleopra
- Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - A Nicoletti
- Neurologic Unit, AOU "Policlinico-San Marco", Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy
| | - C Pacchetti
- Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy
| | - A Di Fonzo
- IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy
| | - M A Volontè
- IRCCS San Raffaele Scientific Institute, Neurology Unit, Milan, Italy
| | - P Barone
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy
| | - M T Pellecchia
- Department of Medicine Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Fisciano, Italy.
| |
Collapse
|
4
|
Ponticorvo S, Manara R, Russillo MC, Erro R, Picillo M, Di Salle G, Di Salle F, Barone P, Esposito F, Pellecchia MT. Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy. Sci Rep 2021; 11:21683. [PMID: 34737396 PMCID: PMC8569168 DOI: 10.1038/s41598-021-01222-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Accepted: 10/22/2021] [Indexed: 11/09/2022] Open
Abstract
Diagnosis of multiple system atrophy (MSA) may be improved by using multimodal imaging approaches. We investigated the use of T1-weighted/T2-weighted (T1w/T2w) images ratio combined with voxel-based morphometry to evaluate brain tissue integrity in MSA compared to Parkinson’s disease (PD) and healthy controls (HC). Twenty-six patients with MSA, 43 patients with PD and 56 HC were enrolled. Whole brain voxel-based and local regional analyses were performed to evaluate gray and white matter (GM and WM) tissue integrity and mean regional values were used for patients classification using logistic regression. Increased mean regional values of T1w/T2w in bilateral putamen were detected in MSA-P compared to PD and HC. The combined use of regional GM and T1w/T2w values in the right and left putamen showed the highest accuracy in discriminating MSA-P from PD and good accuracy in discriminating MSA from PD and HC. A good accuracy was also found in discriminating MSA from PD and HC by either combining regional GM and T1w/T2w values in the cerebellum or regional WM and T1w/T2w in the cerebellum and brainstem. The T1w/T2w image ratio alone or combined with validated MRI parameters can be further considered as a potential candidate biomarker for differential diagnosis of MSA.
Collapse
Affiliation(s)
- S Ponticorvo
- Neuroscience Section, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy
| | - R Manara
- Neuroradiology Unit, Department of Neurosciences, University of Padua, Padua, Italy
| | - M C Russillo
- Neuroscience Section, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy
| | - R Erro
- Neuroscience Section, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy
| | - M Picillo
- Neuroscience Section, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy
| | - G Di Salle
- Classe di Scienze Sperimentali, Scuola Superiore di Studi Universitari e Perfezionamento Sant'Anna, Pisa, Italy
| | - F Di Salle
- Neuroscience Section, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy
| | - P Barone
- Neuroscience Section, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy
| | - F Esposito
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - M T Pellecchia
- Neuroscience Section, Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, 84131, Salerno, Italy.
| |
Collapse
|
5
|
Mongardi L, Rispoli V, Scerrati A, Giordano F, Capone J, Vaudano A, De Bonis P, Morgante F, Picillo M, Cavallo M, Sensi M. Deep brain stimulation of the ventralis oralis anterior thalamic nucleus is effective for dystonic tremor. Parkinsonism Relat Disord 2020; 81:8-11. [DOI: 10.1016/j.parkreldis.2020.09.040] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Revised: 09/25/2020] [Accepted: 09/28/2020] [Indexed: 10/23/2022]
|
6
|
Erro R, Di Fonzo A, Percetti M, Monfrini E, Scannapieco S, Picillo M, Barone P. Childhood-onset dystonia with cerebellar signs: expanding the spectrum of GNAL mutations. Eur J Neurol 2020; 27:e66-e67. [PMID: 32180288 DOI: 10.1111/ene.14220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Accepted: 03/12/2020] [Indexed: 11/27/2022]
Affiliation(s)
- R Erro
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy
| | - A Di Fonzo
- Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.,Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
| | - M Percetti
- Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.,Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
| | - E Monfrini
- Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.,Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
| | - S Scannapieco
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy
| | - M Picillo
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy
| | - P Barone
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy
| |
Collapse
|
7
|
Picillo M, Palladino R, Erro R, Colosimo C, Marconi R, Antonini A, Barone P. The PRIAMO study: active sexual life is associated with better motor and non-motor outcomes in men with early Parkinson's disease. Eur J Neurol 2019; 26:1327-1333. [PMID: 31267621 DOI: 10.1111/ene.13983] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Accepted: 05/06/2019] [Indexed: 12/11/2022]
Abstract
BACKGROUND AND PURPOSE Data suggest a relationship between sexual dysfunction, mainly erectile dysfunction in men, and worse disease progression in Parkinson's disease (PD). There is scant evidence on the correlates of sexual activity in PD patients. By involving a subgroup of 355 patients from the PRIAMO (Parkinson Disease Non Motor Symptoms) study, the present 24-month longitudinal prospective analysis aims to demonstrate that the presence of active sexual life is associated with disease progression in early PD. METHODS AND RESULTS Multivariable mixed-effect logistic regression models showed that gastrointestinal symptoms [odds ratio 0.56, 95% confidence interval (CI) 0.39-0.82, P = 0.003] and apathy (odds ratio 0.42, 95% CI 0.29-0.63, P < 0.001) were less likely to be associated with sexual activity in men. Analysis also demonstrated that sexual activity in men was associated with lower motor disability (coefficient -2.881, 95% CI -4.732 to -1.030, P = 0.002), better quality of life (coefficient -24.196, 95% CI -44.884 to -3.508, P = 0.022; coefficient 0.083, 95% CI 0.023-0.143, P = 0.006) and lower depression scores (coefficient -1.245, 95% CI -2.104 to -0.387, P = 0.004). No association was shown in women. CONCLUSIONS This is the first prospective longitudinal study involving a large cohort of PD patients suggesting that sexual activity is associated with lower motor and non-motor disability as well as with better quality of life in men. These findings should prompt movement disorders specialists to periodically inquiry about their patients' sexual life.
Collapse
Affiliation(s)
- M Picillo
- Department of Medicine, Surgery and Dentistry, Neuroscience Section, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy
| | - R Palladino
- Department of Primary Care and Public Health, School of Public Health, Imperial College of London, London, UK.,Department of Public Health, School of Medicine, University 'Federico II', Naples, Italy
| | - R Erro
- Department of Medicine, Surgery and Dentistry, Neuroscience Section, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy
| | - C Colosimo
- Department of Neurology, Santa Maria University Hospital, Terni, Italy
| | - R Marconi
- Neurology Division, Misericordia Hospital, Grosseto, Italy
| | - A Antonini
- Department of Neurosciences (DNS), Padova University, Padova, Italy
| | - P Barone
- Department of Medicine, Surgery and Dentistry, Neuroscience Section, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy
| | | |
Collapse
|
8
|
Erro R, Picillo M, Amboni M, Savastano R, Scannapieco S, Cuoco S, Santangelo G, Vitale C, Pellecchia MT, Barone P. Comparing postural instability and gait disorder and akinetic‐rigid subtyping of Parkinson disease and their stability over time. Eur J Neurol 2019; 26:1212-1218. [DOI: 10.1111/ene.13968] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2019] [Accepted: 04/04/2019] [Indexed: 01/19/2023]
Affiliation(s)
- R. Erro
- Center for Neurodegenerative Disease – CEMAND Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ University of Salerno Baronissi (SA) Italy
| | - M. Picillo
- Center for Neurodegenerative Disease – CEMAND Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ University of Salerno Baronissi (SA) Italy
| | - M. Amboni
- Center for Neurodegenerative Disease – CEMAND Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ University of Salerno Baronissi (SA) Italy
- Institute of Diagnosis and Health IDC‐Hermitage Capodimonte Naples Italy
| | - R. Savastano
- Azienda Ospedaliera Universitaria 'San Giovanni di Dio e Ruggi d'Aragona' SalernoItaly
| | - S. Scannapieco
- Center for Neurodegenerative Disease – CEMAND Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ University of Salerno Baronissi (SA) Italy
| | - S. Cuoco
- Center for Neurodegenerative Disease – CEMAND Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ University of Salerno Baronissi (SA) Italy
| | - G. Santangelo
- Department of Psychology University of Campania Luigi Vanvitelli CasertaItaly
| | - C. Vitale
- Institute of Diagnosis and Health IDC‐Hermitage Capodimonte Naples Italy
- Department of Motor Sciences and Wellness University ‘Parthenope’ Naples Italy
| | - M. T. Pellecchia
- Center for Neurodegenerative Disease – CEMAND Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ University of Salerno Baronissi (SA) Italy
| | - P. Barone
- Center for Neurodegenerative Disease – CEMAND Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’ University of Salerno Baronissi (SA) Italy
| |
Collapse
|
9
|
Valentino V, Iavarone A, Amboni M, Moschiano F, Picillo M, Petretta V, Cicarelli G. Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation. Funct Neurol 2019; 33:31-35. [PMID: 29633694 DOI: 10.11138/fneur/2018.33.1.031] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Apathy is a state of diminished goal-directed speech, motor activity and emotions. The prevalence of apathy in Parkinson's disease (PD) ranges from 16 to 62%. Several studies have investigated the relationships between apathy and other dimensions of PD, but little is known about possible discrepancies between self-evaluation (SE) and caregiver reporting (CR) of this symptom. The aim of this study is twofold: 1) to investigate the differences in apathy evaluations according to the point of view from which apathy is reported (SE vs CR); 2) to identify the possible relationships between each of the two evaluations (SE and CR) and cognitive and affective dimensions of PD. Forty-eight patients with PD were assessed using the Apathy Evaluation Scale (AES) in its SE and CR versions (AES-SE and AES-CR); cognitive, affective and behavioral symptoms were also assessed. AES-SE scores were significantly higher than AESCR ones. Neither AES version correlated with depression, whereas both correlated with motor impairment, disease stage and behavioral symptoms. Mini-Mental State Examination and Frontal Assessment Battery scores showed significant negative correlations only with AES-SE scores. Our findings suggest that the point of view from which apathy is seen can lead to significant discrepancies, even when using the same tool. This should be taken into account in order to obtain correct assessment of this disabling and distressing symptom.
Collapse
|
10
|
Picillo M, Palladino R, Barone P, Erro R, Colosimo C, Marconi R, Morgante L, Antonini A. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease. Eur J Neurol 2017; 24:788-795. [PMID: 28425642 DOI: 10.1111/ene.13290] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2016] [Accepted: 03/06/2017] [Indexed: 12/12/2022]
Abstract
BACKGROUND AND PURPOSE New venues are currently being explored to predict disease progression in Parkinson's disease (PD), such as non-motor subtypes and models merging motor and non-motor symptoms (NMS). By involving a subgroup of 585 patients from the PRIAMO (Parkinson Disease Non-motor Symptoms) study, the present 24-month longitudinal prospective analysis aimed to demonstrate that urinary dysfunction is an early marker of higher motor and non-motor burden as well as lower health-related quality of life. METHODS AND RESULTS Multivariable mixed-effect logistic regression models controlling for demographic and clinical variables showed that the following NMS domains were associated with urinary dysfunction: gastrointestinal [odds ratio (OR) 2.57, 95% confidence interval (CI) 1.67-3.97, P < 0.001], cardiovascular (OR 2.22, 95% CI 1.18-4.17, P = 0.013), skin (OR 1.81, 95% CI 1.06-3.08, P = 0.029), sleep (OR 2.06, 95% CI 1.34-3.16, P = 0.001), pain (OR 1.85, 95% CI 1.21-2.83, P = 0.004), fatigue (OR 2.40, 95% CI 1.56-3.68, P < 0.001), apathy (OR 2.79, 95% CI 1.72-4.52, P < 0.001) and respiratory (OR 1.82, 95% CI 1.02-3.23, P = 0.039). Analysis also demonstrated that urinary dysfunction was associated with higher motor disability (coefficient 1.73, 95% CI 0.68-2.78, P = 0.001) and lower health-related quality of life (coefficient -0.05, 95% CI -0.08 to -0.02, P < 0.001, and coefficient -3.49, 95% CI -5.21 to -1.77, P < 0.001) but not with more severe cognitive disability (coefficient -0.34, 95% CI -0.92 to 0.24, P = 0.251). CONCLUSIONS This is the first prospective longitudinal study involving a large cohort of PD patients demonstrating the relevance of urinary dysfunction as an early marker of higher motor and non-motor disability as well as lower health-related quality of life. These findings support a role for urinary dysfunction as an early marker of more severe disease progression.
Collapse
Affiliation(s)
- M Picillo
- Neuroscience Section, Department of Medicine and Surgery, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy
| | - R Palladino
- Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.,Department of Public Health, School of Medicine, University 'Federico II', Naples, Italy
| | - P Barone
- Neuroscience Section, Department of Medicine and Surgery, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy
| | - R Erro
- Neuroscience Section, Department of Medicine and Surgery, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Salerno, Italy.,Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Verona, Italy
| | - C Colosimo
- Department of Neurology, Santa Maria University Hospital, Terni, Italy
| | - R Marconi
- Neurology Division, Misericordia Hospital, Grosseto, Italy
| | - L Morgante
- Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, University of Messina, Messina, Italy
| | - A Antonini
- Parkinson and Movement Disorders Unit, IRCCS Fondazione Ospedale San Camillo, Venice, Italy.,Department of Neurosciences (DNS), Padova University, Padova, Italy
| | | |
Collapse
|
11
|
Erro R, Picillo M, Vitale C, Amboni M, Moccia M, Santangelo G, Pellecchia MT, Barone P. The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study. Eur J Neurol 2016; 23:1673-1679. [DOI: 10.1111/ene.13106] [Citation(s) in RCA: 62] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2016] [Accepted: 06/09/2016] [Indexed: 01/16/2023]
Affiliation(s)
- R. Erro
- Sobell Department of Motor Neuroscience and Movement Disorders; UCL Institute of Neurology; London UK
- Department of Neuroscience, Biomedicine and Movement Science; University of Verona; Verona Italy
| | - M. Picillo
- Department of Medicine and Surgery; Center for Neurodegenerative diseases (CEMAND), Neuroscience Section; University of Salerno; Baronissi (SA) Italy
| | - C. Vitale
- University Parthenope; Naples Italy
- IDC-Hermitage-Capodimonte; Naples Italy
| | - M. Amboni
- IDC-Hermitage-Capodimonte; Naples Italy
| | - M. Moccia
- Department of Neuroscience, Reproductive and Odontostomatologic Sciences; University of Naples Federico II; Naples Italy
| | - G. Santangelo
- Department of Psychology, Second University of Naples; Caserta Italy
| | - M. T. Pellecchia
- Department of Medicine and Surgery; Center for Neurodegenerative diseases (CEMAND), Neuroscience Section; University of Salerno; Baronissi (SA) Italy
| | - P. Barone
- Department of Medicine and Surgery; Center for Neurodegenerative diseases (CEMAND), Neuroscience Section; University of Salerno; Baronissi (SA) Italy
| |
Collapse
|
12
|
Pellecchia MT, Picillo M, Santangelo G, Longo K, Moccia M, Erro R, Amboni M, Vitale C, Vicidomini C, Salvatore M, Barone P, Pappatà S. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study. Acta Neurol Scand 2015; 131:275-81. [PMID: 25644029 DOI: 10.1111/ane.12365] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/12/2014] [Indexed: 11/27/2022]
Abstract
OBJECTIVES Mild cognitive impairment (MCI) is a common feature in Parkinson's disease (PD). We performed an exploratory study to investigate dopaminergic nigrostriatal innervation and its cognitive correlates in early untreated PD patients with MCI as compared to cognitively intact patients. PATIENTS AND METHODS A consecutive series of 34-de-novo, drug-naïve patients with PD were enrolled. They underwent [123-I] FP-CIT SPECT and comprehensive neuropsychological battery. MCI was identified in 15 of 34 patients with PD. RESULTS The two groups did not show any statistically significant difference in age, sex, disease duration, education, lateralization, and H&Y and Hospital Anxiety and Depression Scale scores. Logistic regression analysis showed that UPDRS-III was weakly associated with MCI (P = 0.034). Partial correlation analysis controlling for UPDRS-III and age suggested that in PD patients with MCI reduced V3″ values in the more affected caudate were correlated with reduced performances in frontal assessment battery, Trail Making Test: part B minus Part A and copy task of the Rey-Osterrieth complex figure test. Reduced V3″ values in the more and less affected putamen were significantly related with reduced performance in frontal assessment battery and in copy task of Rey-Osterrieth complex figure test, respectively. No correlation was found between neuropsychological scores and DAT availability in PD patients without MCI. CONCLUSIONS Although preliminary, our results suggest that striatal dopamine depletion may contribute to some cognitive deficit in early never treated PD patients with MCI.
Collapse
Affiliation(s)
- M. T. Pellecchia
- Center for Neurodegenerative Diseases; University of Salerno; Salerno Italy
| | - M. Picillo
- Department of Neurological Sciences; University Federico II; Naples Italy
| | - G. Santangelo
- Department of Psychology; Neuropsychology Laboratory; Second University of Naples; Caserta Italy
- IDC Hermitage-Capodimonte; Naples Italy
| | - K. Longo
- IDC Hermitage-Capodimonte; Naples Italy
| | - M. Moccia
- Department of Neurological Sciences; University Federico II; Naples Italy
| | - R. Erro
- Department of Neurological Sciences; University Federico II; Naples Italy
| | - M. Amboni
- IDC Hermitage-Capodimonte; Naples Italy
| | - C. Vitale
- IDC Hermitage-Capodimonte; Naples Italy
- University Parthenope; Naples Italy
| | - C. Vicidomini
- Institute of Biostructure and Bioimaging; CNR; Naples Italy
| | - M. Salvatore
- Department of Advanced Biomedical Sciences; University Federico II; Naples Italy
| | - P. Barone
- Department of Neurological Sciences; University Federico II; Naples Italy
| | - S. Pappatà
- Institute of Biostructure and Bioimaging; CNR; Naples Italy
| |
Collapse
|
13
|
|
14
|
Moccia M, Picillo M, Erro R, Longo K, Amboni M, Santangelo G, Palladino R, Allocca R, Caporale O, Triassi M, Pellecchia MT, Barone P, Vitale C. Increased bilirubin levels in de novo Parkinson's disease. Eur J Neurol 2015; 22:954-9. [PMID: 25740378 DOI: 10.1111/ene.12688] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2014] [Accepted: 12/29/2014] [Indexed: 12/13/2022]
Abstract
BACKGROUND AND PURPOSE Oxidative stress is a central pathogenic mechanism of Parkinson's disease (PD), and the heme oxygenase (HO) bilirubin pathway is one of the main mammalian antioxidative defences. Indeed, there is growing evidence of HO-bilirubin upregulation from early phases of PD. Our aim was to investigate bilirubin as a possible biomarker of PD diagnosis and progression. METHODS A cross-sectional case-control study was performed to evaluate differences in bilirubin levels between newly diagnosed, drug-naïve PD subjects and controls. Afterwards, PD subjects were included in a 2-year longitudinal study to evaluate disease progression in relation to baseline bilirubin levels. RESULTS Seventy-five de novo PD subjects were selected and matched with 75 controls by propensity score. Analysis of variance showed higher bilirubin levels in PD patients compared with controls (P < 0.001). Linear regression analysis failed to show a relationship between bilirubin and Unified Parkinson's Disease Rating Scale (UPDRS) part III (P = 0.283) at baseline evaluation. At 2-year follow-up, indirect relationships between bilirubin levels and UPDRS part III (P = 0.028) and between bilirubin levels and levodopa-equivalent daily dosage (P = 0.012) were found. CONCLUSIONS Parkinson's disease subjects showed higher levels of bilirubin compared with controls. Bilirubin increase might be due to HO overexpression as a compensatory response to oxidative stress occurring from early stages of PD.
Collapse
Affiliation(s)
- M Moccia
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Moccia M, Pappatà S, Erro R, Picillo M, Vitale C, Amboni M, Longo K, Palladino R, Barone P, Pellecchia MT. Uric acid relates to dopamine transporter availability in Parkinson's disease. Acta Neurol Scand 2015; 131:127-31. [PMID: 25288358 DOI: 10.1111/ane.12295] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/22/2014] [Indexed: 01/10/2023]
Abstract
BACKGROUND Diagnosing Parkinson's disease (PD) and tracking its progression may require the combination of reliable biomarkers. Among them, both serum uric acid (UA) and dopamine transporter (DaT) binding deserve more investigations. AIMS OF THE STUDY We aimed to investigate the relationship between serum UA levels and DaT availability in newly diagnosed, drug-naïve PD patients, by means of semiquantitative [(123) I]FP-CIT-SPECT. METHODS We recruited 52 newly diagnosed, drug-naïve PD patients, and performed serum UA dosage and [(123) I]FP-CIT-SPECT. RESULTS Pearson's correlation analysis showed that UA levels were significantly higher in patients with higher averaged, ipsilateral and contralateral DaT binding in caudate, putamen, and striatum. CONCLUSIONS We showed, for the first time, by regional semiquantitative analysis of DaT binding in PD patients that UA levels significantly correlates with the severity of dopaminergic impairment in caudate, putamen, and striatum. This study broadens our knowledge on the importance of UA as a biomarker of PD.
Collapse
Affiliation(s)
- M. Moccia
- Department of Neuroscience, Reproductive Science and Odontostomatology; Federico II University; Naples Italy
| | - S. Pappatà
- Institute of Biostructure and Bioimaging; CNR; Naples Italy
| | - R. Erro
- Sobell Department of Motor Neuroscience and Movement Disorders; University College London (UCL), Institute of Neurology; London UK
- Dipartimento di Scienze Neurologiche e del Movimento; Università di Verona, Policlinico Borgo Roma; Verona Italy
| | - M. Picillo
- Department of Neuroscience, Reproductive Science and Odontostomatology; Federico II University; Naples Italy
| | - C. Vitale
- University of Naples Parthenope; Naples Italy
- IDC Hermitage-Capodimonte; Naples Italy
| | - M. Amboni
- IDC Hermitage-Capodimonte; Naples Italy
| | - K. Longo
- IDC Hermitage-Capodimonte; Naples Italy
| | - R. Palladino
- Department of Primary Care and Public Health; Imperial College; London UK
- Department of Public Health; Federico II University; Naples Italy
| | - P. Barone
- Center for Neurodegenerative Diseases (CEMAND); Neuroscience Section; Department of Medicine; University of Salerno; Salerno Italy
| | - Maria Teresa Pellecchia
- Center for Neurodegenerative Diseases (CEMAND); Neuroscience Section; Department of Medicine; University of Salerno; Salerno Italy
| |
Collapse
|
16
|
Dubbioso R, Picillo M, Amboni M, Iodice R, Barone P, Santoro L, Manganelli F. 84. Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and freezing of gait. Clin Neurophysiol 2015. [DOI: 10.1016/j.clinph.2014.10.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Moccia M, Picillo M, Erro R, Vitale C, Longo K, Amboni M, Santangelo G, Palladino R, Capo G, Orefice G, Barone P, Pellecchia MT. Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease. Eur J Neurol 2014; 22:93-8. [DOI: 10.1111/ene.12533] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2014] [Accepted: 06/09/2014] [Indexed: 12/25/2022]
Affiliation(s)
- M. Moccia
- Department of Neuroscience, Reproductive Science and Odontostomatology; Federico II University; Naples Italy
| | - M. Picillo
- Neuroscience Section; Department of Medicine; Center for Neurodegenerative Diseases (CEMAND); University of Salerno; Salerno Italy
| | - R. Erro
- Sobell Department of Motor Neuroscience and Movement Disorders; University College London (UCL) Institute of Neurology; London UK
- Department of Neurological and Movement Sciences; University of Verona; Policlinico Borgo Roma; Verona Italy
| | - C. Vitale
- IDC Hermitage Capodimonte; Naples Italy
- Department of Motor Sciences; University Parthenope; Naples Italy
| | - K. Longo
- IDC Hermitage Capodimonte; Naples Italy
| | - M. Amboni
- IDC Hermitage Capodimonte; Naples Italy
| | - G. Santangelo
- Neuropsychology Laboratory; Department of Psychology; Second University of Naples; Caserta Italy
| | - R. Palladino
- Department of Primary Care and Public Health; Imperial College; London UK
- Department of Public Health; Federico II University; Naples Italy
| | - G. Capo
- AOU San Giovanni di Dio e Ruggi d'Aragona; Salerno Italy
| | - G. Orefice
- Department of Neuroscience, Reproductive Science and Odontostomatology; Federico II University; Naples Italy
| | - P. Barone
- Neuroscience Section; Department of Medicine; Center for Neurodegenerative Diseases (CEMAND); University of Salerno; Salerno Italy
| | - M. T. Pellecchia
- Neuroscience Section; Department of Medicine; Center for Neurodegenerative Diseases (CEMAND); University of Salerno; Salerno Italy
| |
Collapse
|
18
|
Santangelo G, Vitale C, Trojano L, Picillo M, Moccia M, Pisano G, Pezzella D, Cuoco S, Erro R, Longo K, Pellecchia MT, Amboni M, De Rosa A, De Michele G, Barone P. Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. Eur J Neurol 2014; 22:253-60. [PMID: 24848193 DOI: 10.1111/ene.12467] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2013] [Accepted: 03/26/2014] [Indexed: 12/01/2022]
Abstract
BACKGROUND AND PURPOSE Apathy may be either a symptom of major depression or a behavioral disturbance occurring in concomitance with depression or alone in Parkinson's disease (PD). The aim of the present study was to determine the progression of cognitive impairment in drug-naïve untreated PD patients with or without clinically significant apathy. METHODS Sixty-two PD patients with a disease duration <2 years and without history of present or past therapy with pro-dopaminergic agents were included and underwent the Apathy Evaluation Scale (S-AES), a clinical interview based on diagnostic criteria for apathy and a comprehensive neuropsychological battery to assess memory, frontal functions and visuospatial functions. Two years after the first assessment, all patients were re-evaluated on the S-AES, a clinical interview and neuropsychological tests. RESULTS According to the cut-off value of the S-AES and diagnostic criteria for apathy, eight patients experienced apathy at both baseline and follow-up (A+A+), nine patients had apathy only at follow-up (A-A+), 37 patients never experienced apathy (A-A-) and eight patients showed apathy at the baseline only (A+A-). Cognitive performance significantly declined in all four groups. At both baseline and follow-up A+A+ performed worse than A-A- on visuospatial and frontal tests; A-A+ had lower scores than A-A- on the interference task of the Stroop test (IT-ST). Regression analysis showed that poor performance on the IT-ST at baseline was the only independent predictor of onset of apathy at follow-up. CONCLUSIONS The results indicated a relationship between apathy and dysexecutive syndrome in early PD. Reduced scores on the IT-ST may predict development of apathy in PD patients.
Collapse
Affiliation(s)
- G Santangelo
- Department of Psychology, Second University of Naples, Caserta, Italy; IDC-Hermitage-Capodimonte, Naples, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Picillo M, Barone P, Pellecchia MT, Santangelo G, Kano O, Ikeda K, Iwasaki Y. Evolution of mild cognitive impairment in Parkinson disease. Neurology 2014; 82:1384. [DOI: 10.1212/wnl.0000000000000234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
20
|
Picillo M, Iavarone A, Pellecchia M, Amboni M, Erro R, Moccia M, Vitale C, Longo K, Santangelo G, Spina E, Scannapieco S, Orefice G, Barone P. Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: Our experience on one hundred and thirty-eight healthy subjects. Clin Otolaryngol 2014; 39:53-7. [DOI: 10.1111/coa.12212] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/17/2013] [Indexed: 11/29/2022]
Affiliation(s)
- M. Picillo
- Department of Neuroscience, Reproductive Sciences and Odontostomatology; University Federico II; Naples Italy
| | - A. Iavarone
- Neurological and Stroke Unit; CTO Hospital; AORN Ospedale dei Colli; Naples Italy
| | - M.T. Pellecchia
- Center for Neurodegenerative Diseases (CEMAND); Department of Medicine and Surgery; University of Salerno; Salerno Italy
| | - M. Amboni
- Center for Neurodegenerative Diseases (CEMAND); Department of Medicine and Surgery; University of Salerno; Salerno Italy
- IDC Hermitage-Capodimonte; Naples Italy
| | - R. Erro
- Department of Neuroscience, Reproductive Sciences and Odontostomatology; University Federico II; Naples Italy
| | - M. Moccia
- Department of Neuroscience, Reproductive Sciences and Odontostomatology; University Federico II; Naples Italy
| | - C. Vitale
- IDC Hermitage-Capodimonte; Naples Italy
- University “Parthenope”; Naples Italy
| | - K. Longo
- IDC Hermitage-Capodimonte; Naples Italy
| | - G. Santangelo
- Neuropsychology Laboratory; Department of Psychology; Second University of Naples; Caserta Italy
| | - E. Spina
- Department of Neuroscience, Reproductive Sciences and Odontostomatology; University Federico II; Naples Italy
| | - S. Scannapieco
- Center for Neurodegenerative Diseases (CEMAND); Department of Medicine and Surgery; University of Salerno; Salerno Italy
| | - G. Orefice
- Department of Neuroscience, Reproductive Sciences and Odontostomatology; University Federico II; Naples Italy
| | - P. Barone
- Center for Neurodegenerative Diseases (CEMAND); Department of Medicine and Surgery; University of Salerno; Salerno Italy
| |
Collapse
|
21
|
Picillo M, Amboni M, Erro R, Moccia M, Vitale C, De Michele G, De Rosa A, Santoro L, Orefice G, Pellecchia M, Barone P. Gender differences in non-motor symptoms in early, drug naïve Parkinson'/INS;s disease. J Neurol Sci 2013. [DOI: 10.1016/j.jns.2013.07.482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
22
|
Santangelo G, Vitale C, Trojano L, Angrisano MG, Picillo M, Errico D, Agosti V, Grossi D, Barone P. Subthreshold depression and subjective cognitive complaints in Parkinson's disease. Eur J Neurol 2013; 21:541-4. [PMID: 23790130 DOI: 10.1111/ene.12219] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2012] [Accepted: 05/16/2013] [Indexed: 01/25/2023]
Abstract
BACKGROUND AND PURPOSE Subthreshold depression (SubD) is characterized by clinically relevant depressive symptoms not meeting criteria for major depression. The possible association of SubD with subjective cognitive complaints and/or objective cognitive impairments was investigated in a sample of consecutive, non-demented Parkinson's disease (PD) outpatients. METHODS Amongst 115 patients, SubD was identified in 30 patients, major depression in 33; 36 patients were classified as non-depressed. Enrolled patients were administered tests and questionnaires validated in PD for assessing objective and subjective cognitive dysfunctions. RESULTS On objective cognitive measures SubD patients did not differ from non-depressed patients, whereas depressed patients achieved significantly lower scores than the other two groups. SubD and depressed patients reported more cognitive complaints than non-depressed patients. CONCLUSIONS SubD is a non-motor aspect of PD that is not related to objective cognitive deficits but is associated with subjective cognitive complaints, thus impacting on patients' well-being.
Collapse
Affiliation(s)
- G Santangelo
- Department of Psychology, Second University of Naples, Caserta, Italy; IDC Hermitage-Capodimonte, Naples, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Pellecchia MT, Santangelo G, Picillo M, Pivonello R, Longo K, Pivonello C, Vitale C, Amboni M, De Rosa A, Moccia M, Erro R, De Michele G, Santoro L, Colao A, Barone P. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. Eur J Neurol 2013; 21:802-7. [DOI: 10.1111/ene.12137] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2012] [Accepted: 02/14/2013] [Indexed: 11/30/2022]
Affiliation(s)
- M. T. Pellecchia
- Center for Neurodegenerative Diseases, University of Salerno; Salerno Italy
| | - G. Santangelo
- Department of Psychology; Neuropsychology Laboratory, Second University of Naples; Caserta Italy
- IDC Hermitage-Capodimonte; Naples Italy
| | - M. Picillo
- Department of Neurological Sciences; Federico II University; Naples Italy
| | - R. Pivonello
- Department of Molecular and Clinical Endocrinology and Oncology; Federico II University; Naples Italy
| | - K. Longo
- IDC Hermitage-Capodimonte; Naples Italy
| | - C. Pivonello
- Department of Molecular and Clinical Endocrinology and Oncology; Federico II University; Naples Italy
| | - C. Vitale
- IDC Hermitage-Capodimonte; Naples Italy
- University of Naples Parthenope; Naples Italy
| | - M. Amboni
- IDC Hermitage-Capodimonte; Naples Italy
| | - A. De Rosa
- Department of Neurological Sciences; Federico II University; Naples Italy
| | - M. Moccia
- Department of Neurological Sciences; Federico II University; Naples Italy
| | - R. Erro
- Department of Neurological Sciences; Federico II University; Naples Italy
| | - G. De Michele
- Department of Neurological Sciences; Federico II University; Naples Italy
| | - L. Santoro
- Department of Neurological Sciences; Federico II University; Naples Italy
| | - A. Colao
- Department of Molecular and Clinical Endocrinology and Oncology; Federico II University; Naples Italy
| | - P. Barone
- Center for Neurodegenerative Diseases, University of Salerno; Salerno Italy
| |
Collapse
|
24
|
Erro R, Pappata S, Picillo M, Rocco M, Santangelo G, Barone P, Vitale C. Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism. Neurology 2013; 80:e147. [DOI: 10.1212/wnl.0b013e318289709d] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
25
|
Tessitore A, Amboni M, Cirillo G, Corbo D, Picillo M, Russo A, Vitale C, Santangelo G, Erro R, Cirillo M, Esposito F, Barone P, Tedeschi G. Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am J Neuroradiol 2012; 33:1804-9. [PMID: 22538070 DOI: 10.3174/ajnr.a3066] [Citation(s) in RCA: 89] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE FOG is a troublesome symptom of PD. Despite growing evidence suggesting that FOG in PD may be associated with cognitive dysfunction, the relationship between regional brain atrophy and FOG has been poorly investigated. MATERIALS AND METHODS Optimized VBM was applied to 3T brain MR images of 24 patients with PD and 12 HC. Patients were classified as either FOG- or FOG+ (n = 12) based on their responses to a validated FOG Questionnaire and clinical observation. All patients with PD also underwent a detailed neuropsychological evaluation. RESULTS The VBM analysis in patients with FOG+ showed a reduced GM volume in the left cuneus, precuneus, lingual gyrus, and posterior cingulate cortex compared with both patients with FOG- and HC. We did not detect any significant change of GM volume when comparing HC versus all patients with PD (FOG- and FOG+). FOG clinical severity was significantly correlated with GM loss in posterior cortical regions. Finally, patients with FOG+ scored lower on tests of frontal lobe function. CONCLUSIONS Our findings provide the first evidence that the development of FOG in patients with PD is associated with posterior GM atrophy, which may play a role in the complex pathophysiology of this disabling symptom.
Collapse
Affiliation(s)
- A Tessitore
- Department of Neurological Sciences, Second University of Naples, Naples, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|